{"transactions":[{"id":685540,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-17T22:40:18.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":65000,"derivative":{"exercise_price":43.56,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001191702-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000002/primarydocument.xml","form_type":"4/A","original_submission_date":"2026-08-14"}},{"id":686939,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":65000,"derivative":{"exercise_price":0,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":686938,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2027."}],"balance_after":32500,"derivative":{"exercise_price":0,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":686937,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":6718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026."}],"balance_after":20157,"derivative":{"exercise_price":0,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":6718},"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":686936,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025."}],"balance_after":11563,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":5781},"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":686935,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":2419,"price":43.7985,"value":105948.5715,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.33 to $44.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":17697,"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":686934,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":99,"price":44.5019,"value":4405.6881,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $44.41 to $44.55, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20116,"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":686933,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":59,"price":44.4142,"value":2620.4378,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $44.40 to $44.42, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20215,"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":686932,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":2439,"price":43.8081,"value":106847.9559,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.22 to $44.18, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20274,"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":686931,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":6718,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22713,"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":686930,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:27.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15995,"source":{"system":"sec-edgar","filing":"0001191702-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000119170226000001/primarydocument.xml","form_type":"4"}},{"id":1066475,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T23:43:39.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":161250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":161250,"derivative":{"exercise_price":13.39,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":161250},"source":{"system":"sec-edgar","filing":"0001562180-25-005799","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005799/primarydocument.xml","form_type":"4"}},{"id":1066474,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T23:43:39.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":26875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026."}],"balance_after":26875,"derivative":{"exercise_price":0,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":26875},"source":{"system":"sec-edgar","filing":"0001562180-25-005799","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005799/primarydocument.xml","form_type":"4"}},{"id":1066473,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T23:43:39.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":false,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025."}],"balance_after":17344,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":5781},"source":{"system":"sec-edgar","filing":"0001562180-25-005799","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005799/primarydocument.xml","form_type":"4"}},{"id":1066472,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-14T23:43:39.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":2098,"price":13.3924,"value":28097.2552,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $13.36 to $13.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10214,"source":{"system":"sec-edgar","filing":"0001562180-25-005799","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005799/primarydocument.xml","form_type":"4"}},{"id":1066471,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-14T23:43:39.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":true,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12312,"source":{"system":"sec-edgar","filing":"0001562180-25-005799","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005799/primarydocument.xml","form_type":"4"}},{"id":1156193,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-05-08T01:10:38.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":5209,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-05-01","expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":5209},"source":{"system":"sec-edgar","filing":"0001562180-25-003659","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025003659/primarydocument.xml","form_type":"4"}},{"id":1156192,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-05-08T01:10:38.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":1930,"price":16.4542,"value":31756.606,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6531,"source":{"system":"sec-edgar","filing":"0001562180-25-003659","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025003659/primarydocument.xml","form_type":"4"}},{"id":1156191,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-05-08T01:10:38.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":5209,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8461,"source":{"system":"sec-edgar","filing":"0001562180-25-003659","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025003659/primarydocument.xml","form_type":"4"}},{"id":1400161,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-25T00:25:15.000Z","date":"2024-09-23","kind":"exercise","planned":false,"acquired":false,"shares":20922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":41636,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":20922},"source":{"system":"sec-edgar","filing":"0001562180-24-006946","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006946/primarydocument.xml","form_type":"4"}},{"id":1400160,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-25T00:25:15.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":62558,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001562180-24-006946","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006946/primarydocument.xml","form_type":"4"}},{"id":1400159,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-09-25T00:25:15.000Z","date":"2024-09-23","kind":"sale","planned":false,"acquired":false,"shares":20922,"price":27.6295,"value":578064.399,"ownership":{"direct":true},"balance_after":3252,"source":{"system":"sec-edgar","filing":"0001562180-24-006946","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006946/primarydocument.xml","form_type":"4"}},{"id":1400158,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-09-25T00:25:15.000Z","date":"2024-09-23","kind":"exercise","planned":false,"acquired":true,"shares":20922,"price":0.71,"value":14854.62,"ownership":{"direct":true},"balance_after":24174,"source":{"system":"sec-edgar","filing":"0001562180-24-006946","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006946/primarydocument.xml","form_type":"4"}},{"id":1400157,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-09-25T00:25:15.000Z","date":"2024-09-20","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":28.3702,"value":1418510.0,"ownership":{"direct":true},"balance_after":3252,"source":{"system":"sec-edgar","filing":"0001562180-24-006946","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006946/primarydocument.xml","form_type":"4"}},{"id":1400156,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-09-25T00:25:15.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.71,"value":35500.0,"ownership":{"direct":true},"balance_after":53252,"source":{"system":"sec-edgar","filing":"0001562180-24-006946","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006946/primarydocument.xml","form_type":"4"}},{"id":1433646,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-08-14T20:15:21.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":23125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2024."}],"balance_after":23125,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":23125},"source":{"system":"sec-edgar","filing":"0001562180-24-006260","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006260/primarydocument.xml","form_type":"4"}},{"id":1433645,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T20:15:21.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":138750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on August 12, 2024, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":138750,"derivative":{"exercise_price":17.05,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":138750},"source":{"system":"sec-edgar","filing":"0001562180-24-006260","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006260/primarydocument.xml","form_type":"4"}},{"id":1528395,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T22:31:04.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted to the reporting person which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":5209,"derivative":{"exercise_price":0,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":5208},"source":{"system":"sec-edgar","filing":"0001562180-24-003830","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003830/primarydocument.xml","form_type":"4"}},{"id":1528394,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-05-03T22:31:04.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":1956,"price":18.91,"value":36987.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.68 to $19.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3252,"source":{"system":"sec-edgar","filing":"0001562180-24-003830","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003830/primarydocument.xml","form_type":"4"}},{"id":1528393,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-05-03T22:31:04.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5208,"source":{"system":"sec-edgar","filing":"0001562180-24-003830","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003830/primarydocument.xml","form_type":"4"}},{"id":1651635,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-09T22:43:27.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":false,"shares":8029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest each month beginning on January 3, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":93162,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":8029},"source":{"system":"sec-edgar","filing":"0001562180-24-001227","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024001227/primarydocument.xml","form_type":"4"}},{"id":1651634,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-09T22:43:27.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":false,"shares":3813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest each month beginning on January 3, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":101191,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":3813},"source":{"system":"sec-edgar","filing":"0001562180-24-001227","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024001227/primarydocument.xml","form_type":"4"}},{"id":1651633,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-09T22:43:27.000Z","date":"2024-02-07","kind":"exercise","planned":true,"acquired":false,"shares":17993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest each month beginning on January 3, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":105004,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":17993},"source":{"system":"sec-edgar","filing":"0001562180-24-001227","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024001227/primarydocument.xml","form_type":"4"}},{"id":1651632,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-09T22:43:27.000Z","date":"2024-02-09","kind":"sale","planned":true,"acquired":false,"shares":8029,"price":20.0096,"value":160657.0784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.15, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-001227","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024001227/primarydocument.xml","form_type":"4"}},{"id":1651631,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-09T22:43:27.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":true,"shares":8029,"price":1.93,"value":15495.97,"ownership":{"direct":true},"balance_after":8029,"source":{"system":"sec-edgar","filing":"0001562180-24-001227","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024001227/primarydocument.xml","form_type":"4"}},{"id":1651630,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-09T22:43:27.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":3813,"price":20.0065,"value":76284.7845,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-001227","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024001227/primarydocument.xml","form_type":"4"}},{"id":1651629,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-09T22:43:27.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":true,"shares":3813,"price":1.93,"value":7359.09,"ownership":{"direct":true},"balance_after":3813,"source":{"system":"sec-edgar","filing":"0001562180-24-001227","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024001227/primarydocument.xml","form_type":"4"}},{"id":1651628,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-09T22:43:27.000Z","date":"2024-02-07","kind":"sale","planned":true,"acquired":false,"shares":17993,"price":20.0002,"value":359863.5986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-001227","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024001227/primarydocument.xml","form_type":"4"}},{"id":1651627,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-09T22:43:27.000Z","date":"2024-02-07","kind":"exercise","planned":true,"acquired":true,"shares":17993,"price":1.93,"value":34726.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 30, 2023."}],"balance_after":17993,"source":{"system":"sec-edgar","filing":"0001562180-24-001227","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024001227/primarydocument.xml","form_type":"4"}},{"id":1698641,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-12-28T21:39:04.000Z","date":"2023-12-27","kind":"sale","planned":false,"acquired":false,"shares":8497,"price":10.5,"value":89218.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 30, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 1,932 shares purchased on May 15, 2023 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-23-008572","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023008572/primarydocument.xml","form_type":"4"}},{"id":1801911,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-18T23:13:46.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":200000,"derivative":{"exercise_price":7.08,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001562180-23-006456","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023006456/primarydocument.xml","form_type":"4"}},{"id":1906211,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-05-03T22:26:36.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted to the reporting person which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":10417,"derivative":{"exercise_price":0,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":5208},"source":{"system":"sec-edgar","filing":"0001562180-23-003922","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023003922/primarydocument.xml","form_type":"4"}},{"id":1906210,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-05-03T22:26:36.000Z","date":"2023-05-02","kind":"sale","planned":false,"acquired":false,"shares":1897,"price":8.9049,"value":16892.5953,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $8.59 to $9.58, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6565,"source":{"system":"sec-edgar","filing":"0001562180-23-003922","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023003922/primarydocument.xml","form_type":"4"}},{"id":1906209,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-05-03T22:26:36.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 254 shares purchased on November 15, 2022 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":8462,"source":{"system":"sec-edgar","filing":"0001562180-23-003922","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023003922/primarydocument.xml","form_type":"4"}},{"id":2142277,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-05T20:42:12.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":4730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest each month beginning on January 3, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":122997,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":4730},"source":{"system":"sec-edgar","filing":"0001562180-22-007050","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022007050/primarydocument.xml","form_type":"4"}},{"id":2142276,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-10-05T20:42:12.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":4730,"price":9.7579,"value":46154.867,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $9.47 to $10.00, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-007050","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022007050/primarydocument.xml","form_type":"4"}},{"id":2142275,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-10-05T20:42:12.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":4730,"price":1.93,"value":9128.9,"ownership":{"direct":true},"balance_after":7730,"source":{"system":"sec-edgar","filing":"0001562180-22-007050","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022007050/primarydocument.xml","form_type":"4"}},{"id":2163175,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-08T20:16:41.000Z","date":"2022-09-06","kind":"exercise","acquired":false,"shares":4730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest monthly beginning on January 16, 2021, subject to Reporting Person continuing as a service provider through each vest date."}],"balance_after":127727,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":4730},"source":{"system":"sec-edgar","filing":"0001562180-22-006557","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022006557/primarydocument.xml","form_type":"4"}},{"id":2163174,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-09-08T20:16:41.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":2351,"price":10.992,"value":25842.192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $10.93 to $11.08, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-006557","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022006557/primarydocument.xml","form_type":"4"}},{"id":2163173,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-09-08T20:16:41.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":2379,"price":10.8262,"value":25755.5298,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $9.93 to $10.92, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5351,"source":{"system":"sec-edgar","filing":"0001562180-22-006557","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022006557/primarydocument.xml","form_type":"4"}},{"id":2163172,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-09-08T20:16:41.000Z","date":"2022-09-06","kind":"exercise","acquired":true,"shares":4730,"price":1.93,"value":9128.9,"ownership":{"direct":true},"balance_after":7730,"source":{"system":"sec-edgar","filing":"0001562180-22-006557","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022006557/primarydocument.xml","form_type":"4"}},{"id":2189508,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-10T21:43:08.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 8, 2022, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":200000,"derivative":{"exercise_price":10.39,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001562180-22-006030","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022006030/primarydocument.xml","form_type":"4"}},{"id":2193315,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-05T20:12:40.000Z","date":"2022-08-03","kind":"exercise","acquired":false,"shares":4502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":112558,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":4502},"source":{"system":"sec-edgar","filing":"0001562180-22-005918","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005918/primarydocument.xml","form_type":"4"}},{"id":2193314,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-05T20:12:40.000Z","date":"2022-08-03","kind":"exercise","acquired":false,"shares":4730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":132457,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":4730},"source":{"system":"sec-edgar","filing":"0001562180-22-005918","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005918/primarydocument.xml","form_type":"4"}},{"id":2193313,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-08-05T20:12:40.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":9232,"price":9.3069,"value":85921.3008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $9.07 to $9.55, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005918","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005918/primarydocument.xml","form_type":"4"}},{"id":2193312,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-08-05T20:12:40.000Z","date":"2022-08-03","kind":"exercise","acquired":true,"shares":4502,"price":0.71,"value":3196.42,"ownership":{"direct":true},"balance_after":12232,"source":{"system":"sec-edgar","filing":"0001562180-22-005918","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005918/primarydocument.xml","form_type":"4"}},{"id":2193311,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-08-05T20:12:40.000Z","date":"2022-08-03","kind":"exercise","acquired":true,"shares":4730,"price":1.93,"value":9128.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022."}],"balance_after":7730,"source":{"system":"sec-edgar","filing":"0001562180-22-005918","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005918/primarydocument.xml","form_type":"4"}},{"id":2210787,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-07T20:23:44.000Z","date":"2022-07-06","kind":"exercise","acquired":false,"shares":1046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":137187,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":1046},"source":{"system":"sec-edgar","filing":"0001562180-22-005621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005621/primarydocument.xml","form_type":"4"}},{"id":2210786,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-07T20:23:44.000Z","date":"2022-07-05","kind":"exercise","acquired":false,"shares":4502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":117060,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":4502},"source":{"system":"sec-edgar","filing":"0001562180-22-005621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005621/primarydocument.xml","form_type":"4"}},{"id":2210785,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-07T20:23:44.000Z","date":"2022-07-05","kind":"exercise","acquired":false,"shares":3684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":138233,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":3275},"source":{"system":"sec-edgar","filing":"0001562180-22-005621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005621/primarydocument.xml","form_type":"4"}},{"id":2210784,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-07-07T20:23:44.000Z","date":"2022-07-06","kind":"sale","acquired":false,"shares":1046,"price":8.5352,"value":8927.8192,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $8.44 to $8.60, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005621","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005621/primarydocument.xml","form_type":"4"}},{"id":2210783,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-07-07T20:23:44.000Z","date":"2022-07-06","kind":"exercise","acquired":true,"shares":1046,"price":1.93,"value":2018.78,"ownership":{"direct":true},"balance_after":4046,"source":{"system":"sec-edgar","filing":"0001562180-22-005621","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005621/primarydocument.xml","form_type":"4"}},{"id":2210782,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-07-07T20:23:44.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":8186,"price":8.347,"value":68328.542,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $7.81 to $8.58, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005621","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005621/primarydocument.xml","form_type":"4"}},{"id":2210781,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-07-07T20:23:44.000Z","date":"2022-07-05","kind":"exercise","acquired":true,"shares":4502,"price":0.71,"value":3196.42,"ownership":{"direct":true},"balance_after":11186,"source":{"system":"sec-edgar","filing":"0001562180-22-005621","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005621/primarydocument.xml","form_type":"4"}},{"id":2210780,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-07-07T20:23:44.000Z","date":"2022-07-05","kind":"exercise","acquired":true,"shares":3684,"price":1.93,"value":7110.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022."}],"balance_after":6684,"source":{"system":"sec-edgar","filing":"0001562180-22-005621","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005621/primarydocument.xml","form_type":"4"}},{"id":2225472,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-21","kind":"exercise","acquired":false,"shares":13508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":121562,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":13508},"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225471,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-21","kind":"exercise","acquired":false,"shares":17570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":141917,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":17570},"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225470,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-17","kind":"exercise","acquired":false,"shares":22127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":159487,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":22127},"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225469,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-16","kind":"exercise","acquired":false,"shares":14722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":181614,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":14722},"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225468,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-21","kind":"sale","acquired":false,"shares":31078,"price":7.2944,"value":226695.3632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.72 to $7.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225467,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-21","kind":"exercise","acquired":true,"shares":17570,"price":1.93,"value":33910.1,"ownership":{"direct":true},"balance_after":34078,"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225466,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-21","kind":"exercise","acquired":true,"shares":13508,"price":0.71,"value":9590.68,"ownership":{"direct":true},"balance_after":16508,"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225465,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":22127,"price":6.6179,"value":146434.2733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.21 to $6.89, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225464,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-17","kind":"exercise","acquired":true,"shares":22127,"price":1.93,"value":42705.11,"ownership":{"direct":true},"balance_after":25127,"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225463,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-16","kind":"sale","acquired":false,"shares":14722,"price":6.168,"value":90805.296,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.26, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2225462,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T22:50:53.000Z","date":"2022-06-16","kind":"exercise","acquired":true,"shares":14722,"price":1.93,"value":28413.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022."}],"balance_after":17722,"source":{"system":"sec-edgar","filing":"0001562180-22-005251","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005251/primarydocument.xml","form_type":"4"}},{"id":2231503,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-15","kind":"exercise","acquired":false,"shares":585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":196336,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":585},"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231502,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-15","kind":"exercise","acquired":false,"shares":18075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":135070,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":18075},"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231501,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":3628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":153145,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":3628},"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231500,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-13","kind":"exercise","acquired":false,"shares":4093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":156773,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":4093},"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231499,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-15","kind":"sale","acquired":false,"shares":18075,"price":6.1104,"value":110445.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.22, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231498,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-15","kind":"sale","acquired":false,"shares":585,"price":6.1104,"value":3574.584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.22, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":21075,"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231497,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-15","kind":"exercise","acquired":true,"shares":585,"price":1.93,"value":1129.05,"ownership":{"direct":true},"balance_after":21660,"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231496,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-15","kind":"exercise","acquired":true,"shares":18075,"price":0.71,"value":12833.25,"ownership":{"direct":true},"balance_after":21075,"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231495,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-14","kind":"sale","acquired":false,"shares":3628,"price":6.0239,"value":21854.7092,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.10, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231494,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":3628,"price":0.71,"value":2575.88,"ownership":{"direct":true},"balance_after":6628,"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231493,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-13","kind":"sale","acquired":false,"shares":4093,"price":6.0058,"value":24581.7394,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.02, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2231492,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-15T22:39:20.000Z","date":"2022-06-13","kind":"exercise","acquired":true,"shares":4093,"price":0.71,"value":2906.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022."}],"balance_after":7093,"source":{"system":"sec-edgar","filing":"0001562180-22-005126","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005126/primarydocument.xml","form_type":"4"}},{"id":2236068,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T22:34:07.000Z","date":"2022-06-10","kind":"exercise","acquired":false,"shares":7125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":160866,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":7125},"source":{"system":"sec-edgar","filing":"0001562180-22-005053","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005053/primarydocument.xml","form_type":"4"}},{"id":2236067,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T22:34:07.000Z","date":"2022-06-09","kind":"exercise","acquired":false,"shares":7615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":167991,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":7615},"source":{"system":"sec-edgar","filing":"0001562180-22-005053","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005053/primarydocument.xml","form_type":"4"}},{"id":2236066,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T22:34:07.000Z","date":"2022-06-08","kind":"exercise","acquired":false,"shares":12566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":175606,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":12566},"source":{"system":"sec-edgar","filing":"0001562180-22-005053","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005053/primarydocument.xml","form_type":"4"}},{"id":2236065,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-10T22:34:07.000Z","date":"2022-06-10","kind":"sale","acquired":false,"shares":7125,"price":6.0519,"value":43119.7875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.43, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005053","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005053/primarydocument.xml","form_type":"4"}},{"id":2236064,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-10T22:34:07.000Z","date":"2022-06-10","kind":"exercise","acquired":true,"shares":7125,"price":0.71,"value":5058.75,"ownership":{"direct":true},"balance_after":10125,"source":{"system":"sec-edgar","filing":"0001562180-22-005053","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005053/primarydocument.xml","form_type":"4"}},{"id":2236063,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-10T22:34:07.000Z","date":"2022-06-09","kind":"sale","acquired":false,"shares":7615,"price":6.4868,"value":49396.982,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.39 to $6.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005053","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005053/primarydocument.xml","form_type":"4"}},{"id":2236062,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-10T22:34:07.000Z","date":"2022-06-09","kind":"exercise","acquired":true,"shares":7615,"price":0.71,"value":5406.65,"ownership":{"direct":true},"balance_after":10615,"source":{"system":"sec-edgar","filing":"0001562180-22-005053","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005053/primarydocument.xml","form_type":"4"}},{"id":2236061,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-10T22:34:07.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":12566,"price":6.6339,"value":83361.5874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.44 to $6.73, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001562180-22-005053","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005053/primarydocument.xml","form_type":"4"}},{"id":2236060,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-10T22:34:07.000Z","date":"2022-06-08","kind":"exercise","acquired":true,"shares":12566,"price":0.71,"value":8921.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022."}],"balance_after":15566,"source":{"system":"sec-edgar","filing":"0001562180-22-005053","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005053/primarydocument.xml","form_type":"4"}},{"id":2240261,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T23:03:56.000Z","date":"2022-06-07","kind":"exercise","acquired":false,"shares":17150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":188172,"derivative":{"exercise_price":0.71,"expiration_date":"2030-09-01","underlying":"Common Stock","underlying_shares":17150},"source":{"system":"sec-edgar","filing":"0001562180-22-004887","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022004887/primarydocument.xml","form_type":"4"}},{"id":2240260,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T23:03:56.000Z","date":"2022-06-07","kind":"exercise","acquired":false,"shares":973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":196921,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":973},"source":{"system":"sec-edgar","filing":"0001562180-22-004887","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022004887/primarydocument.xml","form_type":"4"}},{"id":2240259,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22884,"kind":"person","name":"MOORE JOHN R","position":1,"cik":"0001191702","reported_name":"MOORE JOHN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T23:03:56.000Z","date":"2022-06-06","kind":"exercise","acquired":false,"shares":13934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":197894,"derivative":{"exercise_price":1.93,"expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":13934},"source":{"system":"sec-edgar","filing":"0001562180-22-004887","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022004887/primarydocument.xml","form_type":"4"}}],"next_cursor":"2022-06-07T23:03:56.000000Z,2240259"}